Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and pharmacodynamic evaluation of Biphasic Insulin Aspart 30 in healthy volunteers examined the PK/PD profile of this insulin mixture.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED